Latest prostate cancer News | Page 15

Prostate cancer in Australia – what do numbers tell us?
Portable prostate cancer test may help reach underserved men
Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer
Revolutionary 3D imaging maps how breast cancer spreads
Simple solutions for stress-free Christmas
Cancer survival rates are improving in Australia
Active surveillance: where are we now?
Cancer survival rates continue to improve, while death and incidence rates fall
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
Changing face of men’s health
Bold vision to double prostate cancer funding and wipe out deaths from disease by 2040
New centre provides local care and makes Dubbo more attractive for doctors
Telix Pharmaceuticals says first Australian patient doses in global study
Monash receives $41m in NHMRC Ideas Grants
Prostate cancer support group launched in Meekatharra
Lutetium for metastatic castrate resistant prostate cancer
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
$15 million for innovative health and medical research
New support for prostate cancer patients
Coles joins Movember movement to raise funds for men’s health
Additional support for Australian men battling prostate cancer
New prostate cancer treatment subsidy breaks seven-year PBS listing drought
$5 million NHMRC Synergy Grant for Monash University breast and prostate cancer prevention and early detection project
Find Cancer Early campaign relaunched in WA following new survey results
Cancer costs U.S. more than $156 billion, with drugs leading expense
WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists
Tissue-engineered prostate tumours shed light on cancer spread
Lynparza in combination with abiraterone significantly delayed disease progression in all-comers
Financial toxicity: What is it?
TGA grants priority review for Telix Pharmaceuticals’ TLX591-CDx
China Grand Pharma signs A$400m commercial partnership with Telix Pharma
Cricket Australia confirms official charity partners for 2020-21 summer of cricket
New findings speed progress towards affordable gene therapy
Gisborne’s Motivation for Movember
Drug research pivoted from prostate cancer to COVID-19 treatment
Australian-first study on new precision prostate cancer treatment
Covid-19 won’t mask support for men’s health
Australian-first study for new prostate solution
Underlying design mechanism and morphology of humanized bone probed
New standard aims to reduce bill shock for cancer patients
Australian Cricket set for most important Movember yet
Trial helps men with prostate cancer
CFA proudly supports Movember 2020
Genetic risk factors identified for prostate cancer
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Researcher to lead worlds top cancer control group
QUT bioengineer a Eureka Prize finalist
Academic Awards recognize outstanding research at TU/e